BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+23.73%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$8.79B
AUM Growth
+$8.79B
(-49%)
Cap. Flow
-$9.78B
Cap. Flow
% of AUM
-111.33%
Top 10 Holdings %
Top 10 Hldgs %
80.97%
Holding
105
New
4
Increased
25
Reduced
11
Closed
21
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$159M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$98.3M |
| 3 |
Revolution Medicines
RVMD
|
$70.5M |
| 4 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$67.8M |
| 5 |
Replimune Group
REPL
|
$41.9M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.45B |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$337M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$198M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$69.4M |
| 5 |
Roivant Sciences
ROIV
|
$48.1M |
Sector Composition
| 1 | Healthcare | 98.42% |